Evidence mapPaperPMID 40542349Full record

ReviewJournal of translational medicine2025

Heterogeneous tissue-specific macrophages orchestrate metastatic organotropism of breast cancer: implications for promising therapeutics.

Cenzhu Wang, Pinchao Fan, Yu Zhou, Meican Ma, Haowei Zhong, Lei Liu, Qin Chen, Kun Xu

Abstract readReview
In one paragraph

Review in Journal of translational medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Review
  5. Could circulating tumor cells explain why breast conservation improves survival despite higher locoregional recurrence?Translational breast cancer research : a journal focusing on translational research in breast cancer · 2025
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Cenzhu Wang *Department of Oncology, The Affiliated Wuxi People's Hospital of Nanjing Medical University, Wuxi People's Hospital, Wuxi Medical Center, Nanjing Medical University, Wuxi, 214000, China.
Pinchao Fan *Department of Oncology, The First Affiliated Hospital With Nanjing Medical University, Nanjing, 210029, China.
Yu Zhou *Clinical Research Center, The Affiliated Wuxi People's Hospital of Nanjing Medical University, Wuxi People's Hospital, Wuxi Medical Center, Nanjing Medical University, Wuxi, 214000, China.
Meican Ma *Department of Rheumatology, The Affiliated Wuxi People's Hospital of Nanjing Medical University, Wuxi People's Hospital, Wuxi Medical Center, Nanjing Medical University, Wuxi, 214000, China.
Haowei ZhongThe Second School of Clinical Medicine, Nanjing Medical University, Nanjing, 211166, China.
Lei LiuDepartment of Gastroenterology, The Affiliated Yixing Hospital of Jiangsu University, Yixing, 214200, China. liulei20102014@sina.com.
Qin ChenDepartment of Oncology, Ganyu District People's Hospital of Lianyungang City, Lianyungang, 222100, China. 1228196597@qq.com.
Kun XuDepartment of Oncology, Jiangsu Cancer Hospital, Jiangsu Institute of Cancer Research, The Affiliated Cancer Hospital of Nanjing Medical University, 42 Baiziting, Nanjing, 210009, China. njmuxukun@126.com.

Funding

China Postdoctoral Science Foundation 2023M741470Doctoral Talent Fund of the Affiliated Wuxi People's Hospital of Nanjing Medical University BSRC202303General Program of Wuxi Medical Center of Nanjing Medical University WMCG202354General Program of Wuxi Medical Center of Nanjing Medical University WMCG202519Jiangsu Association for Science & Technology Youth Science & Technology Talents Lifting Project JSTJ-2024-386National Natural Science Foundation of China 82403574Research Project of Jiangsu Cancer Hospital SZL202301Research Project of Jiangsu Cancer Hospital ZJ202301Research Project of Lianyungang Anti-Cancer Association ZD202312
6 · The paper itself

Abstract

Compelling evidences have manifested that breast cancer cells prefer to metastasize to certain distant organs, including brain, lung, bone and liver. According to the canonical "seed and soil" theory, this prominent biological behavior, termed as metastatic organotropism, involves intricate interactions between breast cancer cells (the "seeds") and specific residents in the tumor microenvironment (the "soil"), initiating from pre-metastatic niche formation to metastatic outgrowth. Recently, multifaceted heterogeneity of tissue-specific macrophages (TSMs) and their roles played in organotropic metastases of breast cancer are incrementally unveiled. Herein, we decipher multiple diversities of TSMs, including evolvement, profiles, functions and metabolic characteristics under different polarization states. Further, we elaborate on bidirectional effects of TSMs on metastatic organotropism of breast cancer (both to the "seeds" and "soil"), and unearth underlying signaling pathways based on updated mechanistic researches. Lastly, we compile a series of clinical trials, hoping to illuminate promising TSM-targeting therapies against breast cancer organotropic metastases.

Indexed as

Breast NeoplasmsMacrophagesOrgan SpecificityAnimalsFemaleHumansNeoplasm MetastasisSignal TransductionTumor MicroenvironmentBreast cancerMetastatic organotropismSeed and soilTissue-specific macrophageTumor microenvironment

Identifiers

PMID40542349
PMCPMC12181846

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.